Theriva Biologics (TOVX) Assets (2010 - 2026)
Theriva Biologics (TOVX) recorded Assets of $34.86 million in Q2 2026, down 2.7% from $35.83 million a year earlier and down 8.9% from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Theriva Biologics reported Assets of $38.24 million, up 8.2% from FY2024.
- Annual Assets has a five-year compound annual growth rate of 35.4% (FY2020 to FY2025).
- Across earlier years, Assets came in at $35.35 million in FY2024 (-36.0%), $55.22 million in FY2023 (-23.2%), $71.86 million in FY2022 (+2.1%) and $70.37 million in FY2021 (+736.7%).
- Quarterly Assets has ranged from $30.84 million in Q3 2025 to $89 million in Q1 2022 over the past five years.
- On a year-over-year basis, Assets rose in two of the last eight quarters, with an average decline of 14.9%.
- Peak year-over-year performance for Assets in the last five years was growth of 942.9% in Q3 2021, against a decline of 36.0% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $38.25 million (Q1 2026), $38.24 million (Q4 2025) and $30.84 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Theriva Biologics | 10.10 Mn | 10.10 Mn | - | 34.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.86 Mn |
| Mar 31, 2026 | 38.25 Mn |
| Dec 31, 2025 | 38.24 Mn |
| Sep 30, 2025 | 30.84 Mn |
| Jun 30, 2025 | 35.83 Mn |
| Mar 31, 2025 | 32.16 Mn |
| Dec 31, 2024 | 35.35 Mn |
| Sep 30, 2024 | 40.11 Mn |
| Jun 30, 2024 | 42.39 Mn |
| Mar 31, 2024 | 48.73 Mn |
| Dec 31, 2023 | 55.22 Mn |
| Sep 30, 2023 | 61.55 Mn |
| Jun 30, 2023 | 65.45 Mn |
| Mar 31, 2023 | 67.89 Mn |
| Dec 31, 2022 | 71.86 Mn |
| Sep 30, 2022 | 77.11 Mn |
| Jun 30, 2022 | 80.64 Mn |
| Mar 31, 2022 | 89.00 Mn |
| Dec 31, 2021 | 70.37 Mn |
| Sep 30, 2021 | 75.12 Mn |
API Access
Theriva Biologics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();